A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment.
第一作者:
Janet,Hardy
第一单位:
Mater Misericordiae Limited, Mater Research - University of Queensland, Raymond Terrace, Brisbane, QLD, 4101, Australia. Janet.Hardy@mater.org.au.;Department Palliative and Supportive Care, Mater Health Services, Raymond Terrace, South Brisbane, QLD, 4101, Australia. Janet.Hardy@mater.org.au.
作者:
医学主题词
老年人(Aged);止吐药(Antiemetics);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);恶心(Nausea);肿瘤(Neoplasms);诊疗准则(主题)(Practice Guidelines as Topic)
DOI
10.1186/s12885-018-4404-8
PMID
29720113
发布时间
2019-02-15
- 浏览13
BMC cancer
510页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



